Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.420
-0.055-1.00%
Volume:59.35M
Turnover:324.24M
Market Cap:101.26B
PE:35.74
High:5.530
Open:5.455
Low:5.415
Close:5.475
52wk High:8.647
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.65
T/O Rate:0.32%
Dividend:0.12
Dividend Rate:2.22%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.66
PE(LYR):35.74
PS:2.57

Loading ...

Sino Biopharm’s NDA for First-in-Class Long-Acting Ropivacaine Analgesic Accepted by China CDE

Bulletin Express
·
Jul 03

SBP GROUP's New Painkiller Application Accepted for Review

Stock News
·
Jul 03

Sino Biopharmaceutical - China's Cde Accepts New Drug Application for Ropivacaine Hydrochloride Sustained-release Solution

THOMSON REUTERS
·
Jul 03

Sino Biopharmaceutical Stock Climbs 2.6% in Hong Kong

Dow Jones
·
Jul 03

Movement Alert|Sino Biopharmaceutical Rises 4.76% in Regular Trading, National Medical Insurance Catalog Adjustment Favors Innovative Drug Companies

Market Focus
·
Jul 03

Stock Track | SBP GROUP Soars 5.19% Intraday on Regulatory Approvals for Drug Pipeline

Stock Track
·
Jul 03

Sino Biopharmaceutical (SEHK:1177) Advances Pipeline As Valuation Signals Stay Mixed

Simply Wall St.
·
Jul 03

Sino Biopharmaceutical Stock Advances 4.8% in Hong Kong

Dow Jones
·
Jul 02

Sino Biopharm trims outstanding shares by 40.35 million in June, confirms public-float compliance

Bulletin Express
·
Jul 02

Stock Track | SBP GROUP Soars 7.26% Intraday on Strategic AI Investment, Drug Approvals and Sector Rally

Stock Track
·
Jul 02

Movement Alert|Sino Biopharmaceutical Rises 4.99% in Regular Trading, Pharmaceutical Sector Rally Combined with Strategic AI Investment

Market Focus
·
Jul 02

Sino Biopharmaceutical Stock Rises 5.4% in Hong Kong

Dow Jones
·
Jun 29

Stock Track | SBP GROUP Soars 5.63% Intraday on Buyback Plan, Pipeline Milestones, and Sector Rally

Stock Track
·
Jun 29

Movement Alert|Sino Biopharmaceutical Rises 3.05% in Regular Trading, Pharmaceuticals Sector Rallies Broadly Amid Buyback Support and Pipeline Momentum

Market Focus
·
Jun 29

SPB Group Allocates HK$49.1 Million for Share Buyback on June 25

Stock News
·
Jun 25

Sino Biopharmaceutical Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 25

Sino Biopharmaceutical Stock Sheds 3.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Jun 25

Movement Alert|Sino Biopharmaceutical Falls 3.17% in Regular Trading, Pharmaceutical Sector Retreats Again Amid Persistent High Short-Selling Ratio

Market Focus
·
Jun 25

Stock Track | SBP GROUP Soars 5.03% Intraday on Dual Pipeline Catalysts and Share Buyback Program

Stock Track
·
Jun 24

Movement Alert|Sino Biopharmaceutical Rises 3.2% in Regular Trading, Dual Pipeline Catalysts and Sector Recovery Drive Gains

Market Focus
·
Jun 24